Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Palliat Med. 2010 Dec;13(12):1407-13. doi: 10.1089/jpm.2010.0261. Epub 2010 Nov 24.
Palliative medicine has made rapid progress in establishing its scientific and clinical legitimacy, yet the evidence base to support clinical practice remains deficient in both the quantity and quality of published studies. Historically, the conduct of research in palliative care populations has been impeded by multiple barriers including health care system fragmentation, small number and size of potential sites for recruitment, vulnerability of the population, perceptions of inappropriateness, ethical concerns, and gate-keeping.
A group of experienced investigators with backgrounds in palliative care research convened to consider developing a research cooperative group as a mechanism for generating high-quality evidence on prioritized, clinically relevant topics in palliative care.
The resulting Palliative Care Research Cooperative (PCRC) agreed on a set of core principles: active, interdisciplinary membership; commitment to shared research purposes; heterogeneity of participating sites; development of research capacity in participating sites; standardization of methodologies, such as consenting and data collection/management; agile response to research requests from government, industry, and investigators; focus on translation; education and training of future palliative care researchers; actionable results that can inform clinical practice and policy. Consensus was achieved on a first collaborative study, a randomized clinical trial of statin discontinuation versus continuation in patients with a prognosis of less than 6 months who are taking statins for primary or secondary prevention. This article describes the formation of the PCRC, highlighting processes and decisions taken to optimize the cooperative group's success.
姑息医学在确立其科学和临床合法性方面取得了迅速进展,但支持临床实践的证据基础在发表研究的数量和质量方面仍然存在不足。从历史上看,姑息治疗人群的研究受到多种障碍的阻碍,包括医疗保健系统碎片化、潜在招募地点的数量和规模较小、人群的脆弱性、不适当的看法、伦理问题和把关。
一组具有姑息治疗研究背景的经验丰富的研究人员聚集在一起,考虑成立一个研究合作小组,作为在姑息治疗中优先考虑的、具有临床相关性的课题上生成高质量证据的机制。
由此产生的姑息治疗研究合作组织(PCRC)就一系列核心原则达成一致:积极的、跨学科的成员;致力于共同的研究目的;参与地点的异质性;参与地点的研究能力的发展;方法的标准化,如同意和数据收集/管理;对来自政府、行业和研究人员的研究请求做出灵活响应;关注转化;姑息治疗未来研究人员的教育和培训;能够为临床实践和政策提供信息的可操作结果。对第一项合作研究达成了共识,即对预计生存期不足 6 个月且正在服用他汀类药物进行一级或二级预防的患者,他汀类药物停药与继续治疗的随机临床试验。本文描述了 PCRC 的形成,重点介绍了为优化合作小组的成功而采取的过程和决策。